Blockade of AP1 Transactivation Abrogates the Abnormal Expression of Breast Cancer-specific Gene 1 in Breast Cancer Cells
Open Access
- 1 August 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (35) , 31364-31372
- https://doi.org/10.1074/jbc.m201060200
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Regulation and composition of activator protein 1 (AP-1) transcription factors controlling collagenase and c-Jun promoter activitiesBiochemical Journal, 2001
- Regulation and composition of activator protein 1 (AP-1) transcription factors controlling collagenase and c-Jun promoter activitiesBiochemical Journal, 2001
- The p38 SAPK Pathway Regulates the Expression of the MMP-9 Collagenase via AP-1-Dependent Promoter ActivationExperimental Cell Research, 2001
- Transcriptional Regulation of the p67 GenePublished by Elsevier ,2001
- Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequencesOncogene, 2001
- Induced expression of dominant-negative c-jun downregulates NF?B and AP-1 target genes and suppresses tumor phenotype in human keratinocytesMolecular Carcinogenesis, 2000
- Transcriptional suppression of synuclein γ (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin MBreast Cancer Research and Treatment, 2000
- Identification of a Novel Sterol-independent Regulatory Element in the Human Low Density Lipoprotein Receptor PromoterPublished by Elsevier ,2000
- Identification, localization and characterization of the human γ-synuclein geneHuman Genetics, 1998
- Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytesOncogene, 1998